Business Context and Reporting Period
This Form 8-K was filed by Sunshine Heart, Inc. (not Nuwellis, Inc.) on January 16, 2013, reporting events occurring on January 15, 2013. The filing details the entry into a material definitive agreement to raise capital through a common stock purchase arrangement.
Key Financial Metrics and Transaction Details
- Total Commitment: Aspire Capital Fund, LLC is committed to purchase up to $25,000,000 of the Company's common stock over a two-year term.
- Initial Issuance: The Company issued 80,257 "Commitment Shares" immediately upon signing the agreement.
- Initial Purchase Amount: Upon effectiveness of the registration statement, the Company will sell $1,000,000 of stock (Initial Purchase Shares).
- Use of Proceeds: Proceeds are designated for general corporate purposes and working capital requirements.
- Financial Covenants: The agreement contains no financial or business covenants, restrictions on future fundings, or limitations on the use of proceeds.
Material Changes and Mechanism
The Company has established a flexible mechanism to sell shares to Aspire Capital on any business day, subject to market conditions and a minimum stock price of $1.00 per share. The two primary methods are:
- Regular Purchase: Up to 50,000 shares per day at a price based on the lower of the lowest sale price on the date of sale or the average of the three lowest closing prices over the preceding 12 business days. Daily sales are capped at $1,000,000.
- VWAP Purchase: Up to 30% of the trading volume on the purchase date at a price equal to the lower of the closing sale price or 95% of the volume-weighted average price (VWAP).
The Company retains sole discretion to issue purchase notices and may terminate the agreement at any time without penalty. Aspire Capital is prohibited from short selling or hedging the Company's stock.
Guidance, Risks, and Contingencies
- Ownership Cap: Issuances are restricted if they would cause Aspire Capital to beneficially own more than 13.99% of outstanding shares (or 19.99% if the Company delists from the Australian Securities Exchange).
- Registration Rights: The Company agreed to file a registration statement by January 29, 2013, to register the resale of shares by Aspire Capital and to keep it effective.
- Market Risk: The actual proceeds and number of shares issued depend on market conditions and the Company's capital needs; the $25 million figure represents a maximum potential, not a guaranteed amount.
Key Facts for Investor Verification
- Verify the actual number of shares issued for the initial $1,000,000 purchase once the registration statement becomes effective.
- Monitor the Company's stock price relative to the $1.00 threshold required to initiate sales under the agreement.
- Review the filed Registration Rights Agreement (Exhibit 4.1) for specific indemnification liabilities.
- Confirm the Company's current cash position and immediate working capital needs to assess the likelihood of utilizing the full $25 million commitment.